Breakthrough DNA Analysis Technology to Hasten Problem Diagnosis
|
By LabMedica International staff writers Posted on 25 Aug 2014 |

Image: A technical breakthrough for DNA imaging has been achieved that should quicken diagnosis of diseases for which analysis of DNA from single-cells is critical, such as early stage cancers and various pre-natal conditions (Photo courtesy of McGill University and Génome Québec Innovation Center).
Researchers have achieved a technical breakthrough that should result in speedier diagnosis of diseases for which analysis of DNA from single-cells is critical, such as early stage cancers and various prenatal conditions.
The key discovery lies in a new tool developed by a team led by Sabrina Leslie and Walter Reisner, both professors of physics at McGill University (Montreal, QC, Canada), and their collaborator Dr. Rob Sladek of the McGill University & Génome Québec Innovation Center (MUGQ Innovation Center; Montreal, Quebec, Canada). The tool enables the loading of long strands of DNA into a tunable nanoscale imaging chamber in ways that maintain structural identity and conditions similar to their in vivo physiology. This breakthrough method – “Convex Lens-Induced Confinement” (CLIC) (also referred to as convex lens-induced nanoscale templating (CLINT)) – will permit a rapid imaging-based mapping of large genomes while simultaneously identifying specific gene sequences from single cells with single-molecule resolution, a process critical to diagnosing certain types of diseases.
Existing tools used for single-cell genomic analysis rely on side-loading DNA and under pressure into nanochannels in the imaging chamber, a practice that breaks the DNA molecules into small pieces, making it a challenge to later reconstruct the genome. The CLIC tool can be set on top of a standard inverted fluorescence microscope and its innovative aspect lies in the fact that it allows strands of DNA to be loaded into the imaging chamber – from above – and in a process that allows the strands of DNA to maintain their integrity.
“It’s like squeezing many soft spaghetti noodles into long narrow tubes without breaking them,” explains Prof. Leslie, “Once these long strands of DNA are gently squeezed down into nanochannels from a nanoscale bath above, they become effectively rigid which means that we can map positions along uniformly stretched strands of DNA, while holding them still. This means diagnostics can be performed quickly, one cell at a time, which is critical for diagnosing many prenatal conditions and the onset of cancer.”
“Current practices of genomic analysis typically require tens of thousands of cells worth of genomic material to obtain the information we need, but this new approach works with single cells,” said Dr. Sladek, “CLIC will allow researchers to avoid having to spend time stitching together maps of entire genomes as we do under current techniques, and promises to make genomic analysis a much simpler and more efficient process.”
“Nanoscale physics has so much to offer biomedicine and diagnostics,” added Prof. Leslie, “CLIC brings the nanoscale regime to the bench top, and genomics is just the beginning”.
The work was described by Berarda DJ et al. in the journal Proceedings of the National Academy of Sciences of the United States of America (PNAS), August 4, 2014, online ahead of print.
Related Links:
McGill University
The McGill University and Génome Québec Innovation Center
The key discovery lies in a new tool developed by a team led by Sabrina Leslie and Walter Reisner, both professors of physics at McGill University (Montreal, QC, Canada), and their collaborator Dr. Rob Sladek of the McGill University & Génome Québec Innovation Center (MUGQ Innovation Center; Montreal, Quebec, Canada). The tool enables the loading of long strands of DNA into a tunable nanoscale imaging chamber in ways that maintain structural identity and conditions similar to their in vivo physiology. This breakthrough method – “Convex Lens-Induced Confinement” (CLIC) (also referred to as convex lens-induced nanoscale templating (CLINT)) – will permit a rapid imaging-based mapping of large genomes while simultaneously identifying specific gene sequences from single cells with single-molecule resolution, a process critical to diagnosing certain types of diseases.
Existing tools used for single-cell genomic analysis rely on side-loading DNA and under pressure into nanochannels in the imaging chamber, a practice that breaks the DNA molecules into small pieces, making it a challenge to later reconstruct the genome. The CLIC tool can be set on top of a standard inverted fluorescence microscope and its innovative aspect lies in the fact that it allows strands of DNA to be loaded into the imaging chamber – from above – and in a process that allows the strands of DNA to maintain their integrity.
“It’s like squeezing many soft spaghetti noodles into long narrow tubes without breaking them,” explains Prof. Leslie, “Once these long strands of DNA are gently squeezed down into nanochannels from a nanoscale bath above, they become effectively rigid which means that we can map positions along uniformly stretched strands of DNA, while holding them still. This means diagnostics can be performed quickly, one cell at a time, which is critical for diagnosing many prenatal conditions and the onset of cancer.”
“Current practices of genomic analysis typically require tens of thousands of cells worth of genomic material to obtain the information we need, but this new approach works with single cells,” said Dr. Sladek, “CLIC will allow researchers to avoid having to spend time stitching together maps of entire genomes as we do under current techniques, and promises to make genomic analysis a much simpler and more efficient process.”
“Nanoscale physics has so much to offer biomedicine and diagnostics,” added Prof. Leslie, “CLIC brings the nanoscale regime to the bench top, and genomics is just the beginning”.
The work was described by Berarda DJ et al. in the journal Proceedings of the National Academy of Sciences of the United States of America (PNAS), August 4, 2014, online ahead of print.
Related Links:
McGill University
The McGill University and Génome Québec Innovation Center
Latest Technology News
- Interoperable Data Platform Standardizes Multi-Cancer Blood Test Results
- Training Device Improves Accuracy of Pooled Molecular Diagnostics
- New CE-Certified Software Advances Whole-Genome Cancer Testing
- National Rare Disease Registry Standardizes Genetic and Clinical Data for Coordinated Care
- AI Platform Links Biomarker Results to Cancer Clinical Trials and Guidelines
- Agentic AI Platform Supports Genomic Decision-Making in Oncology
- Algorithm Panel Aids Liver Fibrosis Assessment and Liver Cancer Surveillance
- Mailed Screening Kits Help Reduce Colorectal Cancer Screening Gaps
- AI-Enabled Assistant Unifies Molecular Workflow Planning and Support
- AI Tool Automates Validation of Laboratory Software Configuration Changes
- Point-of-Care Testing Enhances Health Literacy and Self-Management in Chronic Disease
- Fully Automated Sample-to-Insight Workflow Advances Latent TB Testing
- Tumor-on-a-Chip Platform Models Pancreatic Cancer Treatment Response
- New Platform Captures Extracellular Vesicles for Early Cancer Detection
- Microfluidic Single-Cell Assay Predicts Breast Cancer Risk
- AI Tool Predicts Non-Response to Targeted Therapy in Colorectal Cancer
Channels
Clinical Chemistry
view channel
Blood Test Enters UK Primary Care Pathway for Earlier Alzheimer’s Diagnosis
Alzheimer’s disease is often first suspected in primary care, yet definitive evaluation frequently depends on specialized imaging or cerebrospinal fluid testing. This creates a persistent gap between disease... Read more
Machine Learning Model Shows Promise for Improving Metanephrine Testing Accuracy
Pheochromocytomas and paragangliomas are rare tumors that form in or near the adrenal glands and cause overproduction of stress hormones. Plasma-free metanephrines are the recommended first-line test,... Read moreMolecular Diagnostics
view channel
AI-Powered Liquid Biopsy Detects Liver Cancer Across Diverse Populations
Liver cancer remains a leading cause of cancer mortality worldwide, with incidence rising alongside the growing burden of metabolic liver disease. Early detection can substantially improve outcomes, yet... Read more
Circular RNAs Enable Noninvasive Cancer Detection and Risk Assessment
Liquid biopsy promises earlier cancer detection and agile treatment monitoring, but robust biomarkers that are stable and disease‑specific remain a hurdle. Circular RNAs (circRNAs) are structurally resilient... Read moreHematology
view channel
Age-Specific CBC Reference Intervals Support Pediatric Diagnosis in Vietnam
Complete blood count (CBC) results underpin pediatric evaluation for anemia, infection, inflammation, and platelet disorders. Yet laboratories in Vietnam have largely relied on reference intervals derived... Read more
Spectral Flow Cytometry Assay Enhances MRD Detection in Multiple Myeloma
Minimal residual disease (MRD) monitoring is pivotal in multiple myeloma, where persistent malignant plasma cells drive relapse risk and help guide therapy decisions. In the United States, approximately... Read moreImmunology
view channel
Study Reveals Immune Mechanism Driving Severe COVID-19 Progression
Severe COVID-19 has highlighted gaps in understanding of early antiviral responses, particularly why some patients deteriorate despite timely care. Type I interferons are central to host defense, yet their... Read more
Antibody Profiling Identifies Preclinical Inflammatory Bowel Disease Years Before Diagnosis
Inflammatory bowel disease often develops after a prolonged symptom-free period, complicating timely recognition and clinical intervention. Limited understanding of immune activity during this silent phase... Read more
Ultrasensitive Blood Test Detects Sjögren’s Signature Years Before Diagnosis
Sjögren’s disease is a common autoimmune condition that can be difficult to recognize early, leading to delayed diagnosis and persistent symptom burden. It affects around half a million people in the UK... Read more
New Assays Expand Cytokine Testing for Transplant and Immunocompromised Patients
Eurofins Viracor has introduced three plasma-based assays—CXCL9 (Test Code 33607), CXCL10 (Test Code 33609), and interleukin-18 (IL-18) (Test Code 33611)—expanding its immunology testing menu for transplant... Read moreMicrobiology
view channel
New Sensitive Blood Assay Detects Tuberculosis Antigen Directly in Blood
Tuberculosis continues to be a leading global infectious disease, and diagnosis still hinges on sputum samples that many patients cannot produce early in illness. Delays in confirming Mycobacterium tuberculosis... Read more
High-Throughput Automated Platform to Advance Latent Tuberculosis Testing
Testing for tuberculosis remains a persistent global need, with demand driven by immigration screening, pre-treatment evaluation for immunosuppressive therapies, and public health programs.... Read morePathology
view channel
AI Pathology Tool Predicts Relapse Risk in Stage II Colorectal Cancer
Bowel cancer is Australia’s fourth most commonly diagnosed cancer and the second leading cause of cancer death, while remaining the third most common cancer worldwide. In stage-two disease, determining... Read more
AI Pathology Tool Stratifies Rectal Cancer to Guide Chemoradiotherapy
Choosing intensified regimens for locally advanced rectal cancer is challenging because these therapies can cause serious side effects. Colorectal cancer is the fourth-most fatal cancer in the UK, and... Read more
PD-L1 Assay Guides Pembrolizumab Eligibility in Ovarian, Fallopian Tube, and Peritoneal Cancers
Agilent Technologies’ PD-L1 IHC 22C3 pharmDx (Code SK006) has received European Union certification as a companion diagnostic to aid in identifying patients with epithelial ovarian, fallopian tube, or... Read moreIndustry
view channelPartnership Brings Automated Pathology Archiving Solutions to U.S. Labs
Accurate retention and retrieval of pathology blocks and slides underpin timely, reliable cancer diagnoses, yet manual archiving remains labor-intensive and error-prone for many laboratories.... Read more







